Skip to main content

Find Clinical Trials

Home
Conditions
Communicable Diseases

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,158 public trials 553 recruiting studies

Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults

NCT00252148

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Rockefeller University Hospital New York, United States

University of Rochester Medical Center Rochester, New York, United States

View Trial Details

Completed

Safety and Immunogenicity of a Plasmid HIV Vaccine in HIV Uninfected Adults

NCT00249106

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: Rockefeller University Hospital New York, United States

University of Rochester Medical Center Rochester, New York, United States

View Trial Details

Completed

Efficacy of Raltegravir in a Large Urban HIV Clinical Population in Milan

NCT01467349

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Infectious Diseases Department Milan, Italy

View Trial Details

Completed

Safety and Immunogenicity of TBC-M4, a MVA HIV Vaccine Alone or in a Prime-Boost Regimen With ADVAX DNA HIV Vaccine

NCT00902824

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: St Stephen's Centre Chelsea and Westminster Hospital London, United Kingdom

View Trial Details

Completed

Safety and Immunogenicity Study of 2 Investigational Preventive HIV Vaccines

NCT01264445

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Kenya AIDS Vaccine Initiative Nairobi, Kenya

Uganda Virus Research Institute-IAVI Entebbe, Uganda

Medical Research Council Masaka, Uganda

Zambia-Emory HIV Research Project Lusaka, Zambia

View Trial Details

Completed

A Study Evaluating the Safety and Clinical Activity of HCV-796 in Treatment-Naive and Non-Responder Subjects

NCT00367887

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Pfizer Investigational Site Anaheim, California, United States

Pfizer Investigational Site La Jolla, California, United States

Pfizer Investigational Site La Jolla, California, United States

Pfizer Investigational Site Los Angeles, California, United States

View all 35 locations

View Trial Details

Completed

Antiretroviral-Sparing Concept With HIV-specific T Cell Precursors With High Proliferative Capacity (PHPC)

NCT00918840

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: IRCCS Policlinico S. Matteo Pavia, Italy

View Trial Details

Completed

Role of HIV on Glutathione Synthesis and Oxidative Stress

NCT01355198

Conditions: Blood-Borne Infections, Communicable Diseases, Erythrocyte Glutathione Deficiency, +13 more
Locations: Baylor GCRC Houston, Texas, United States

View Trial Details

Completed

Acceptability of Hepatitis B Vaccination in General Population

NCT01782794

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Not specified

View Trial Details

Completed

Efficacy and Safety of Ypeginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B

NCT01143662

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: 302 Military Hospital Beijing, China

Beijing Youan Hospital, Capital Medical University Beijing, China

Beijing Youyi Hospital, Capital Medical University Beijing, China

Peking University First Hospital Beijing, China

View all 39 locations

View Trial Details